Brazil vs Zimbabwe: Population requiring preventive chemotherapy for schistosomiasis
Brazil
2.21 million
in 2024
Zimbabwe
2.71 million
in 2024
Brazil rank
29th
Zimbabwe rank
27th
Population requiring preventive chemotherapy for schistosomiasis over time
- Brazil
- Zimbabwe
How they compare
Zimbabwe currently reports 2.71 million against 2.21 million in Brazil, a difference of 500,340.
That makes Zimbabwe's figure about 1.2 times Brazil's.
The two have swapped places 2 times across 15 shared years of data; in 2010 it was Zimbabwe ahead.
Brazil ranks 29th and Zimbabwe ranks 27th of 52 countries.
Zimbabwe has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 1.52 million | 3.52 million | 2.00 million | Zimbabwe |
| 2020s | 2.20 million | 2.82 million | 624,222 | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher population requiring preventive chemotherapy for schistosomiasis, Brazil or Zimbabwe?
- Zimbabwe, at 2.71 million against 2.21 million in Brazil as of 2024.
- What is the difference in population requiring preventive chemotherapy for schistosomiasis between Brazil and Zimbabwe?
- 500,340, with Zimbabwe ahead.
- How many years of comparable data are there for Brazil and Zimbabwe?
- 15 years are reported by both, from 2010 to 2024.
- How do Brazil and Zimbabwe rank globally for population requiring preventive chemotherapy for schistosomiasis?
- Brazil ranks 29th and Zimbabwe ranks 27th of 52 countries.
- Where does this data come from?
- Our World in Data, published as Population requiring preventive chemotherapy for schistosomiasis. Statizoid refreshes it automatically from the source and publishes the full history for both places.